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Abstract. 
 
Rab proteins are small molecular weight 
GTPases that control vesicular traffic in eucaryotic 
cells. A subset of Rab proteins, the Rab3 proteins are 
thought to play an important role in regulated exocyto-
sis of vesicles. In transfected AtT-20 cells expressing 
wild-type Rab3D, we find that a fraction of the protein 
is associated with dense core granules. In the same 
cells, expression of a mutated isoform of Rab3D, 
Rab3D N135I, inhibits positioning of dense core gran-
ules near the plasma membrane, blocks regulated se-
cretion of mature ACTH, and impairs association of 
Rab3A to membranes. Expression of Rab3D N135I 
does not change the levels of ACTH precursor or the 
efficiency with which the precursor is processed into 
ACTH hormone and packaged into dense core gran-
ules. We also find that cells expressing mutated Rab3D 
differentiate to the same extent as untransfected AtT-
20 cells. We conclude that expression of Rab3D N135I 
specifically impairs late membrane trafficking events 
necessary for ACTH hormone secretion.
 
R
 
ab
 
 proteins are small monomeric GTPases proposed
to function as key regulators of vesicular traffic
(33, 38). Rab3 proteins, a family of highly homolo-
gous Rab isoforms, are abundant in cells with regulated
secretory pathways (14). There are four Rab3 isoforms
known: Rab3A, Rab3B, Rab3C, and Rab3D (1, 27, 43,
51). In neurons, Rab3A and Rab3C are associated with
synaptic vesicles (12, 13). In adrenal medullary cells and
rat islets, Rab3A is associated with hormone-containing
secretory granules (7, 8, 34). Rab3B is abundant in epithe-
lial cells (49). Rab3D is found associated with zymogen-
containing granules in the acinar cells of the pancreas and
in the chief cells of gastric glands (41, 44).
The exact role of Rab3 proteins in regulated exocytosis
is unknown. Rab3A is involved in neurotransmission.
Transgenic mice lacking Rab3A have depressed synaptic
transmission after repetitive stimulation (5, 16, 17). Func-
tional data indicate that Rab3A and Rab3C dissociate
from synaptic vesicles during neurotransmitter release (13,
15). Rab3A dissociation is coupled to GTP hydrolysis, in-
dicating that the GTP/GDP cycle of Rab3A is important
for regulated exocytosis (39). In PC12 cells, adrenal chro-
maffin cells, and insulin-secreting cells, overexpression of
Rab3A inhibits Ca
 
2
 
1
 
-dependent exocytosis of dense core
granules (20, 22, 34). In PC12 cells, overexpression of
Rab3B or mutated Rab3B N135I stimulates norepineph-
rine secretion (50). Rab3A and Rab3B may function as
positive and negative regulators of epinephrine release, re-
spectively. Members of the Rab3 family have also been
shown to regulate exocytosis of zymogen-containing gran-
ules (21, 32), degranulation in mast cells (31), and exocyto-
sis in pituitary cells (24). Rab3 isoforms may also regulate
intracellular targeting of exocytotic vesicles to their re-
lease site (30).
AtT-20 cells are neuroendocrine cells that express pro-
opiomelanocortin and process it into mature ACTH hor-
mone (18, 25, 35). AtT-20 cells have constitutive secretory
vesicles and dense core granules that release ACTH hor-
mone in response to stimulation by secretagogues (19).
Both constitutive and regulated secretory vesicles are ac-
cumulated at the tips of the processes (28). To investigate
the role of Rab3D in exocytosis, we have transfected AtT-
20 cells with a mutated isoform of Rab3D, Rab3D N135I.
The analogous mutation in Sec4 (Sec4 N133I; 48) or
Rab3A (Rab3A N135I; 4) makes these proteins unable to
bind GTP. Sec4 N133I and Rab3A N135I behave as domi-
nant-negative mutations and inhibit constitutive and regu-
lated secretion, respectively (22, 48). We predicted that
Rab3D N135I, when expressed in AtT-20 cells, would act
as a dominant-negative mutant. We find that expression of
Rab3D N135I induces changes in the distribution of dense
core granules and impairs regulated secretion of ACTH.
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Materials and Methods
 
Materials
 
Rabbit polyclonal antibodies against the amino-terminal region of Rab3D
were previously described (2). The monoclonal antibodies CL 42.2 against
Rab3A (29) and monoclonal antibodies against synaptobrevin II/vesicle-
associated membrane protein (VAMP)
 
1
 
-2 were provided by R. Jahn
(Yale University School of Medicine, New Haven, CT) (10, 46). Rabbit
polyclonal antibody against Rab4 was provided by P. van der Sluijs (Utrecht
University, Utrecht, the Netherlands) (45). The following reagents were
purchased from commercial sources: monoclonal antibodies against syn-
aptosomal-associated protein of 25 kD (SNAP-25) from Sternberger
Monoclonals Inc. (Baltimore, MD); monoclonal antibodies against synap-
totagmin from Stressgen Biotechnologies Corp. (Victoria, British Colum-
bia, Canada); mouse monoclonal antibodies against ACTH 1-24 from
Peninsula Laboratories Inc. (Belmont, CA); Cy3-conjugated donkey anti–
mouse IgG and FITC-conjugated donkey anti–rabbit IgG from Jackson
ImmunoResearch Laboratories Inc. (West Grove, PA), 10 nm colloidal
gold-labeled protein A from Sigma Chemical Co. (St. Louis, MO).
 
Subcellular Fractionation, Sodium Carbonate 
Extraction, Gel Electrophoresis, and Immunoblotting
 
P2 fraction was prepared as described by Gumbiner et al. (18). Separation
of proteins by SDS-PAGE, immunoblotting, densitometry, and protein
determination were all performed as described (37).
 
Preparation of Rab3D N135I
 
A fragment of Rab3D cDNA containing the whole coding region was ex-
cised from pcDNA1 plasmid with BamH1 and BanI. Recessed 3
 
9
 
 termini
were filled with Klenow fragment of 
 
Escherichia coli
 
 DNA polymerase I
and subcloned into the SmaI site of pBluescript SK II vector (Stratagene,
La Jolla, CA). Site-directed mutagenesis (Kunkel, 1985) was done with a
kit (Muta-Gene Phagemid 
 
in vitro
 
 Mutagenesis Kit; Bio-Rad Laborato-
ries, Hercules, CA), according to the manufacturer’s instructions. Rab3D
N135I, in which Asn-135 of Rab3D was changed to Ile-135, was generated
using the mutagenic oligonucleotide primer 5
 
9
 
-CAG GTC ACA CTT
AAT CCC CAC GAG GAT-3
 
9
 
. The mutation was confirmed by sequenc-
ing of the entire coding region. Rab3D and Rab3D N135I cDNAs were
excised from pBluescript SK II vector with XhoI, and then subcloned into
the SalI site of vector pCB7 (42). The vector pCB7 contains the cytomega-
lovirus promoter, a hygromycin B (GIBCO BRL, Gaithersburg, MD) re-
sistance element, and an SV-40 polyadenylation site.
 
Cell Culture and Transfection
 
AtT-20 cells were cultured in DME supplemented with 10% FBS. Cells
were transfected with Rab3D-pcB7 and Rab3D N135I-pcB7 using the Li-
pofectin Reagent (GIBCO BRL) according to the manufacturer’s instruc-
tions. Stably transfected colonies were selected by growth in presence of
hygromycin B (GIBCO BRL) used at a dilution of 1:1,000. Colonies were
tested for expression of exogenous Rab3D and Rab3D N135I proteins by
Western blot with Rab3D antibody. We selected four clonal cell lines for
further studies: A3C1 and A3C4 cells, which express identical levels of
Rab3D N135I; C6 cells, which express 20-fold more exogenous Rab3D
than the endogenous protein; and C2 cells, which were transfected with
 
Rab3D
 
-pcB7 plasmid and hygromycin B resistant, but did not overexpress
wild-type Rab3D.
 
Immunofluorescence Staining
 
For immunofluorescence analysis, AtT-20 cells were grown on poly-
 
l
 
-lysine–coated coverslips for at least 24 h, briefly washed with PBS at
room temperature, and then fixed for 20 min at room temperature in PBS
containing 4% parafomaldehyde. AtT-20 cells were then permeabilized
with PBS solution containing 0.2% vol/vol Triton X-100 for 10 min at
room temperature, and then washed three times with PBS. Incubations
with primary and secondary antibodies were done as described before
(26). We used affinity-purified rabbit polyclonal antibodies against Rab3D
at 1:100 dilution and monoclonal antibodies against ACTH at 1:1,000 dilu-
tion. Cy3-conjugated donkey anti–mouse IgG and FITC-conjugated don-
key anti–rabbit IgG were used at a final concentration of 30 
 
m
 
g/ml. Confo-
cal microscopy was performed with a scanning laser confocal attachment
(model LSM 410; Carl Zeiss, Inc., Thornwood, NY) mounted on an in-
verted fluorescence microscope (model 100 TV Axiovert; Carl Zeiss,
Inc.). Optical sections were 1 
 
m
 
m thick. Images were processed using
Adobe Photoshop software (Adobe Systems, Inc., San Jose, CA).
 
Electron Microscopy
 
Cells were grown on coverslips in the same conditions as for optical mi-
croscopy. After a brief rinse in PBS, cells attached to a glass surface were
fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.3, for 10
min at room temperature, and then for 20 min at 4
 
8
 
C. Cells were then
rinsed in 0.1 M phosphate buffer, pH 7.3, postfixed with 1% osmium
tetroxide in the same buffer for 1 h at 4
 
8
 
C, dehydrated in ascending alco-
hols, and then treated with propylene oxide. After embedding in Araldite
(Electron Microscopy Sciences, Ft. Washington, PA), ultrathin sections of
the cell monolayers were cut with a Reichert OM ultramicrotome. Sec-
tions were stained with uranyl and lead citrate, and then examined with an
electron microscope (model 100S or 1200EX; JEOL USA, Inc., Peabody,
MA). To quantitate positioning of dense core granules, 10 electron micro-
graphs of AtT-20 and A3C1 cells were taken at random. The magnifica-
tion of the electron micrograph negatives was 5,000
 
3
 
 and that of the final
printed micrographs was 10,000
 
3
 
. Quantitation of the number of dense
core granules per micron length of plasma membrane and the number of
dense core granules per 
 
m
 
m
 
2
 
 perinuclear cytoplasm was done using the
Mop-Videoplan Image analysis system (Kontron Electronic Group, Mu-
nich, Germany).
 
Immunoelectron Microscopy
 
Immunogold labeling of agarose-embedded AtT-20 cells was performed
using the broken cells method described elsewhere (9, 21). To obtain bro-
ken AtT-20 cells, preconfluent AtT-20 cells cultured in one 72-cm
 
2
 
 flask
were washed in PBS, and then scraped in 2 ml of ice-cold homogenization
buffer containing 250 mM sucrose, 25 mM KCl, 2 mM EGTA, and 10 mM
sodium phosphate, pH 6.5. Cells were lightly homogenized by passing
them through a 20-gauge needle with a 5-ml syringe twice. Cells were
fixed by addition of 15 vol of ice-cold fixative solution containing 0.3 M
sucrose, 3% paraformaldehyde, 0.25% glutaraldehyde, and 5 mM sodium
phosphate, pH 6.5. Cells were kept in fixative solution for 30 min, pelleted
by centrifugation at 1,000 
 
g
 
 for 10 min, and then resuspended in 4 vol of
120 mM sodium phosphate, pH 7.5. The entire procedure was carried out
at 4
 
8
 
C. Broken cells were agarose embedded as described (9). Incubations
of agarose-embedded samples with affinity-purified Rab3D antibodies at
a dilution of 1:20 was done as described (21). For gold immunolabeling, 10
nm colloidal gold-conjugated protein A was used at 1:20 dilution.
 
ACTH Release Assay
 
70% confluent cells plated at least 72 h before the assay were rinsed three
times with DME medium at 37
 
8
 
C. Cells were then incubated for 1 h at
37
 
8
 
C with or without 5 mM 8-Br-cAMP in 0.4 ml buffer A, pH 7.4, con-
taining 150 mM NaCl, 20 mM Hepes, 0.70 mM CaCl
 
2
 
, 5 mM KCl, 1 mM
MgCl
 
2
 
, and 0.1 mg/ml bovine serum albumin. The cell medium was col-
lected and then proteins were precipitated by the addition of 1.6 ml of ac-
etone. After overnight incubation at 
 
2
 
20
 
8
 
C, precipitates were collected by
centrifugation in an Eppendorf centrifuge (Brinkman Instruments, West-
bury, NY) operated at maximal speed for 20 min. Samples were resus-
pended in 0.16 ml and 20–80 
 
m
 
l were used for SDS-PAGE electrophoresis.
After blotting onto nitrocellulose, bands were visualized with anti-ACTH
monoclonal antibody by the enhanced chemiluminescence method as de-
scribed elsewhere (37).
 
Results
 
Rab3A and Rab3D Immunofluorescence Distribution 
with Respect to the ACTH-containing Compartment
 
We investigated the relative distribution of Rab3D and
ACTH by double immunofluorescence experiments ana-
lyzed by confocal microscopy. ACTH immunofluores-
cence was more concentrated at the perinuclear Golgi re-
 
1. 
 
Abbreviations used in this paper
 
:
 
 
 
SNAP-25, synaptomal-associated pro-
tein of 25 kD; VAMP, vesicle-associated membrane protein. 
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gion and at the tips of the neurite-like processes (Fig. 1 
 
B
 
,
 
red
 
). In the same cell, Rab3D staining (
 
A
 
), is a more uni-
form green fluorescence in the cytoplasm of the cell body,
the processes, and the tips. When the two images were
merged (
 
C
 
), we found: (
 
a
 
) yellow puncta of Rab3D and
ACTH fluorescence more concentrated at the cell body
(
 
arrows
 
) and at their tips, indicating colocalization of
Rab3D and ACTH; (
 
b
 
) puncta of red ACTH fluorescence
that do not correspond to puncta of green fluorescence
(
 
arrowheads
 
), and (
 
c
 
) areas of prevalent green Rab3D im-
munoreactivity, particularly evident in the cytoplasm of
the processes. The immunofluorescence pattern was simi-
lar in C6 cells overexpressing exogenous Rab3D (data not
shown).
To determine whether Rab3D is associated with dense
core granules, we did immunoelectronmicroscopy on aga-
rose-embedded, broken AtT-20 and C6 cells expressing
wild-type Rab3D. We could not detect any gold staining in
samples from untransfected AtT-20 cells. In samples from
C6 cells expressing exogenous wild-type Rab3D, immu-
nogold particles were found associated with dense core
granules (Fig. 2). Plasma membranes near the granules
were unlabeled (
 
arrowheads
 
, 
 
A
 
 and 
 
C
 
). Nuclear mem-
branes (data not shown), mitochondria (
 
m
 
), and viruses
(
 
v
 
) were also unlabeled. From the immunofluorescence
and the immunoelectronmicroscopy data, we conclude that a
fraction of Rab3D is associated with dense core granules.
 
Expression of Rab3D N135I in AtT-20 Cells
 
To analyze the function of Rab3D in AtT-20 cells, we gen-
erated a mutated isoform of Rab3D, Rab3D N135I. In Fig.
3, it is shown that in the homogenate of A3C1 cells trans-
fected with Rab3D N135I, there are two Rab3D-immu-
noreactive bands. The upper band comigrates with endog-
enous Rab3D in untransfected AtT-20 cells. The lower
band corresponds to Rab3D N135I. Thus, Rab3D N135I,
like Rab3A N135I and Rab3B N135I, has a higher electro-
phoretic mobility than the wild-type protein (4, 50). By
measuring the recovery of Rab3D in the pellet and the su-
pernatant fractions of the experiment shown in Fig. 3, we
estimated that 
 
.
 
90% of cellular wild-type and mutated
Rab3D is associated with membranes. We find that
Rab3D N135I, like Rab3D (26), cannot be solubilized
from membranes by incubation in carbonate buffer at pH
11.5. Thus, membrane-bound Rab3D N135I is an integral
membrane component, like Rab3D. Two Rab3D-immu-
noreactive bands are detectable in the supernatant frac-
tion from A3C1 cells. The lower band has the same mobil-
ity as Rab3D N135I in the pellet fraction of A3C1 cells,
and presumably corresponds to cytosolic, isoprenylated
Rab3D N135I. The upper Rab3D-immunoreactive band in
the A3C1 supernatant may correspond to soluble endoge-
nous Rab3D and/or to unprenylated Rab3D N135I. This
possibility is based on the observation that unprenylated
Figure 1. Distribution of Rab3D and ACTH in
AtT-20 cells. Double immunofluorescence analy-
sis of Rab3D (A, green) and ACTH (B, red) dis-
tribution by confocal microscopy. Overlay (C).
Cells were labeled with affinity-purified rabbit
antipeptide antibody against Rab3D (1:100 dilu-
tion) and mouse monoclonal antibodies against
ACTH (1:1,000) dilution. The second costaining
was performed with FITC-conjugated donkey
anti–rabbit IgG and Cy3-conjugated donkey
anti–mouse IgG. Puncta where Rab3D and
ACTH staining coincide are indicated by arrows;
puncta of predominant ACTH immunoreactivity
are indicated by arrowheads. Bar, 5 mM. 
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GTPases migrate slower than the prenylated proteins after
SDS-PAGE electrophoresis (23).
 
Distribution of Dense Core Granules in Cells 
Expressing Rab3D N135I
 
Mutations in the GTPase domain of individual Rab pro-
teins affect vesicular traffic at distinct sites of the secretory
pathway. Since Rab3D is found associated with dense core
granules, we asked if there were differences in the distri-
bution and/or morphology of these organelles in AtT-20
cells versus A3C1 cells expressing the presumed domi-
nant-negative isoform Rab3D N135I. In the electron mi-
crographs of Fig. 4, the distribution of dense core granules
for each cell type is illustrated. For AtT-20 cells (Fig. 4, 
 
ar-
rows
 
, 
 
C
 
 and 
 
D
 
), dense core granules are clearly positioned
near the plasma membrane of the cell body (
 
arrowheads
 
).
Dense core granules of similar size are accumulated at the
tips of the processes (data not shown). In A3C1 cells ex-
pressing Rab3D N135I, the majority of dense core gran-
ules are scattered in the cytoplasm (Fig. 4, 
 
A
 
 and 
 
B
 
). We
could observe accumulation of dense core granules at the
tips of the processes of A3C1 cells (data not shown). We
quantified the relative distibution of granules found near
the plasma membrane and in the perinuclear cytoplasm of
AtT-20 cells and A3C1 cells (Fig. 5). The data indicate
Figure 2. Immunogold localization of Rab3D. Immunogold staining of broken
cells overexpressing wild-type Rab3D. Immunogold particles were associated
with dense core granules (A–C). Plasma membrane found in the vicinity of la-
beled granules was unstained (arrowheads, A and C). Endogenous murine leu-
kemia virus (MuLV) particles (19) (v, C) and mitochondria (m, C) were unla-
beled. Bar, 0.2 mM. 
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that expression of mutated Rab3D N135I in AtT-20 cells
inhibits recruiting dense core granules at the cell surface.
Immunofluorescence experiments with antitubulin anti-
bodies show a similar pattern in A3C1 and AtT-20 cells
(data not shown). Thus, impaired positioning of granules
near the plasma membrane in A3C1 cells is not because of
obvious changes in the arrangement of the cytoskeleton.
 
Regulated and Constitutive Secretion of ACTH in 
A3C1 Cells
 
The release of precursor and mature ACTH by AtT-20
and A3C1 cells is illustrated in Fig. 6. The proteins se-
creted into the medium were analyzed by Western blot
analysis. AtT-20 cells and A3C1 cells expressing mutated
Rab3D secrete similar amounts of 32-kD ACTH precur-
sors and 23-kD intermediate forms (35), and there is little
or no increase in the intensity of these bands after stimula-
tion with 5 mM 8-Br-cAMP (
 
top
 
). Incubation with 5 mM
8-Br-cAMP induces a sharp increase in secretion of the
mature, glycosylated 13-kD form of ACTH (11) in the me-
dium of AtT-20 cells (
 
bottom
 
). Stimulation of A3C1 cells
with 8-Br-cAMP induced only a modest increase of ma-
ture ACTH secretion, indicating that expression of Rab3D
N135I inhibits regulated hormone secretion. In our hands,
the 5-kD unglycosylated form of ACTH was less abundant
than the 13-kD glycosylated form of ACTH in the culture
medium of stimulated AtT-20 cells (data not shown).
However, the 5-kD ACTH band is more abundant than
the 13-kD band in AtT-20 cell extracts, as shown below. It
is possible that proteolytic enzymes secreted in the cell
medium cleave the unglycosylated form of ACTH during
the 1-h incubation at 37
 
8
 
C.
Fig. 7 is a summary of the ACTH secretion data ob-
tained from several experiments. In mock transfected cells
(clone C2) or cells expressing 20-fold excess of exogenous
wild-type Rab3D (clone C6), regulated secretion of ACTH
is as efficient as in untransfected AtT-20 cells. Inhibition
of 8-Br-cAMP-induced ACTH secretion occurs only in
clones A3C1 and A3C4, which express similar levels of
Rab3D N135I. These experiments show that expression of
Rab3D N135I, but not overexpression of wild-type Rab3D
(clone 6), is able to inhibit mature ACTH secretion.
Cells expressing Rab3D N135I may be unable to secrete
mature ACTH because they produce less of the mature
hormone than wild-type AtT-20 cells. To test this possibil-
ity, we analyzed the content of ACTH immunoreactive
species in AtT-20 and A3C1 cell extracts. P2 fractions,
which contain dense core granules (18) from both cell
lines, were analyzed by Western blot with the ACTH anti-
body (Fig. 8, 
 
left
 
). AtT-20 and A3C1 cells have identical
amounts of 29-, 34-, and 23-kD ACTH precursor and in-
termediate forms (36). These cells also have the same lev-
els of mature glycosylated and unglycosylated ACTH (the
13- and 5-kD protein bands, respectively). Thus, expres-
sion of mutated Rab3D has no effect on the ability of AtT-
20 cells to express proopiomelanocortin and to process
precursor ACTH to the mature hormone. These data indi-
cate that expression of Rab3D N135 inhibits vesicular traf-
fic in the ACTH secretory pathway, but does not interfere
with the process of precursor maturation.
The inability of cells expressing Rab3D N135I to secrete
mature ACTH may be because of a lack of differentiation.
Fractions P2 from AtT-20 cells and A3C1 cells were ana-
lyzed in the same experiment for their content of synap-
totagmin, VAMP-2/synaptobrevin-2, SNAP-25, and Rab3A
(Fig. 8, 
 
right
 
). These proteins are thought to function in
neurotransmission and other regulated secretory pathways
(3, 40). The amount of synaptotagmin, VAMP-2/synapto-
brevin-2, and SNAP-25 per milligram of protein is similar
in A3C1 and AtT-20 cells. Our results indicate that A3C1
and AtT-20 cells differentiate to a similar extent. Rab3A
levels in fraction P2 from A3C1 cells were fivefold lower
than in fraction P2 from AtT-20 cells. This result is further
analyzed in Fig. 10.
Cells expressing Rab3D N135I may be unable to secrete
ACTH because the hormone is not packaged in dense
core granules. P2 fraction contains partially purified dense
core granules (18). We further fractionated P2 membranes
from AtT-20 and A3C1 cells by sucrose density gradient
centrifugation. The distribution of ACTH precursor and
ACTH hormone was identical in samples from AtT-20
cells and A3C1 cells. ACTH precursor (34-kD form) mi-
grated as a wide peak in fractions 6–11. Processed ACTH
hormones (13- and 6-kD forms) were concentrated in frac-
tions 9 and 10 (Fig. 9). Thus, ACTH hormone is packaged
in organelles of similar density in AtT-20 cells and A3C1
cells. Synaptotagmin is a membrane component of synap-
tic vesicles and neuropeptide-containing dense core vesi-
cles (47). After sucrose density centrifugation of P2 frac-
tions, synaptotagmin immunoreactivity distributed as a
unique peak comigrating with ACTH hormone. This ob-
servation indicates that the pool of synaptotagmin recov-
ered in fraction P2 is associated with dense core granules.
Thus, the amount of ACTH hormone per unit membrane
Figure 3. Rab3D N135I is predominantly membrane bound. One
10-cm diam plate of AtT-20 or A3C1 cells transfected with
Rab3D N135I was rinsed twice with ice-cold homogenization
buffer containing 250 mM sucrose, 10 mM Hepes buffer, pH 7.4,
2 mM EGTA, and 1 mM EDTA. Cells were scraped in 0.8 ml ho-
mogenization buffer containing 300 mg/ml PMSF, 1.5 mg/ml leu-
peptin, and 6 mg/ml aprotinin, homogenized with 12 strokes in a
Teflon pestle homogenizer (0.08–0.13-mm clearance), and then
centrifuged at 95,000 rpm in a TLA 100.2 rotor of the Beckman
TL Optima centrifuge (Beckman Instruments, Fullerton, CA).
The pellet was resuspended in 0.8 ml of homogenization buffer.
The lanes of the SDS-PAGE gel were loaded with 40 mg protein
of AtT-20 and A3C1 cells homogenates (H, 1% of total homoge-
nate fraction), pellets (P, 2% of total membrane fraction) and su-
pernatants (S, 4% of total supernatant fraction). The blot was
probed with antibodies against Rab3D (1:1,000 dilution). Bands
were visualized by enhanced chemiluminescence. 
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component of granules (refer to Fig. 8) seems to be similar
or identical in AtT-20 and A3C1 cells. We conclude that in
A3C1 cells expressing Rab3D N135I, packaging of pro-
cessed ACTH hormone in dense core granules occurs with
the same efficiency as in control cells.
Rab3A levels are 10-fold lower in the P2 fraction from
A3C1 cells as compared to the same fraction from AtT-20
cells. In Fig. 10 
 
A
 
, it is shown that total amounts of Rab3A
in the homogenate from A3C1 cells is only twofold less
abundant than in the control. After 30 min of centrifuga-
tion at 400,000 
 
g
 
, we find that the supernatants (
 
S
 
) of
A3C1 and AtT-20 cells contain similar levels of Rab3A
immunoreactivity. However, there is approximately five-
fold less Rab3A protein in the membrane-containing pel-
let (
 
P
 
) from A3C1 than in the same fraction from AtT-20
cells. In the same experiment, we find that there is no inhi-
bition of Rab4 binding to the pellet fraction of A3C1 cells.
These data indicate that in A3C1 cells, there is a relative
inability of Rab3A to bind to cellular organelles, rather
than a defect in the biosynthesis of Rab3A. The lower lev-
els of Rab3A in the homogenate of A3C1 cells may be be-
cause of enhanced degradation of mislocalized Rab3A. In
Fig. 10 
 
B
 
, it is shown that P2 fraction from C6 cells, which
expresses high levels of wild-type Rab3D, has normal lev-
els of Rab3A protein. Thus, inhibition of Rab3A associa-
tion with membranes is because of the N135I mutation,
Figure 4. Distribution of
dense core granules in AtT-
20 cells and in cells express-
ing Rab3D N135I. Electron
micrograph of the cell body
of A3C1 cells (A and B) and
AtT-20 cells (C and D). In
AtT-20 cells the majority of
dense core granules (arrows)
at the cell body are posi-
tioned near the plasma mem-
brane (arrowheads). In A3C1
cells granules are dispersed
in the cytoplasm. The small-
diameter, clear vesicles ap-
proaching the plasma mem-
brane (asterisk) in A3C1 and
AtT-20 cells correspond to
the endogenous murine leuke-
mia virus (MuLV) particles
(19). The virus particles could
also be visualized in clusters
in the extracellular space. A
and C (or B and D) are at the
same magnification.Baldini et al. Rab3D and ACTH Secretion 311
rather than to overexpression of Rab3D. Expression of
mutated Rab3D N135I does not inhibit association of en-
dogenous wild-type Rab3D to P2 membranes. These data
indicate that mutated Rab3D N135I specifically inhibits
association of Rab3A with an intracellular membrane
compartment.
Discussion
Our immunofluorescence experiments indicate that a frac-
tion of endogenous Rab3D colocalizes with ACTH immu-
noreactivity in AtT-20 cells. These data are in agreement
with the findings of Chavez et al. (6) in that exogenous,
epitope tagged Rab3D colocalizes with ACTH at the tips
of AtT-20 cells and at the cell body. By immunoelectron
microscopy in AtT-20 cells expressing exogenous Rab3D,
we find that the protein is specifically associated with
dense core granules. These data indicate that Rab3D func-
tions at late stages in the ACTH secretory pathway.
To test whether Rab3D is involved in the ACTH secre-
tory pathway, we transfected AtT-20 cells with a presumed
dominant-negative mutant of Rab3D, Rab3D N135I. We
then asked whether there were differences in the morphol-
ogy and/or distribution of dense core granules in cells ex-
pressing mutated Rab3D as compared to control cells. In
untransfected AtT-20 cells, most of the granules in the cell
body are found near the plasma membrane. This observa-
tion is consistent with other reports indicating that in neu-
roendocrine PC12 cells, the majority of dense core gran-
ules are docked at the plasma membrane (36). In A3C1
cells expressing Rab3D N135I, dense core granules were
randomly localized in the cytoplasm of the cell body. The
defect in granule positioning is not because of obvious
changes in the architecture of the cytoskeleton, since the
Figure 8. AtT-20 and A3C1 cells have similar amounts of ACTH
precursor and mature forms. 50 mg of P2 fractions from AtT 20
and A3C1 cells were loaded into SDS-PAGE gel. Blots on the
left panel were probed with ACTH monoclonal antibodies. The
upper and the lower halves of the blot were exposed for autora-
diography as described in Fig. 6. Blots on the right panel were
probed with synaptotagmin at 1:1,000 dilution, VAMP-2 antibod-
ies at 1:5,000 dilution, SNAP-25 antibodies at 1:200 dilution, and
Rab3A antibodies at 1:1,000 dilution.
Figure 6. Regulated ACTH
secretion is inhibited in AtT-
20 cells expressing Rab3D
N135I. The lanes of SDS-
PAGE gel (15% acryla-
mide) were loaded with
polypeptides secreted by
AtT-20 cells during a 1-h in-
cubation with or without
8-br-cAMP. The blot was
probed with monoclonal anti-
body against ACTH 1:1,000.
Bands were visualized by en-
hanced chemiluminescence.
The upper and lower halves of the blot were exposed for autora-
diography for 10 s and 1 min, respectively. The specificity of
bands detected with a monoclonal antibody against ACTH was
controlled in preliminary experiments by using the antibody in
presence of 1 mM 1–24 ACTH peptide. Detection of all protein
bands with the exception of a 14-kD band (Fig. 8, bottom) was
abolished by incubation with the ACTH peptide.
Figure 5. Comparison of
granules distribution along
the plasma membrane in
A3C1 cells and AtT-20 cells.
The relative concentration of
granules along the plasma
membrane was calculated as
the ratio of granules/mm of
plasma membrane to gran-
ules/mm2 of cytoplasm. The
granules along the plasma
membrane (granules/mm mem-
brane) are those found
within 200 nm of the cell sur-
face. In AtT-20 cells, 186
granules were counted along
696.1  mm of plasma mem-
brane (0.267 granules/mm).
In the same cells, 121 gran-
ules were found in 1,326.2
mm2 of cytoplasm (0.091 granules/mm2). In A3C1 cells, 84 gran-
ules were counted along 736.4 mm of plasma membrane (0.114
granules/mm). In the same cells, 379 granules were found in
1,184.0  mm2 of cytoplasm space (0.320 granules/mm2).
Figure 7. Quantitation of
ACTH secretion by AtT-20
cells and AtT-20 cells ex-
pressing Rab3D N135I. The
cell lines used for the experi-
ments were: untransfected
AtT-20 cells; cells transfected
with  Rab3D-pcB7 plasmid
which did not overexpress
wild-type Rab3D (clone C2);
AtT-20 cells overexpressing
wild-type Rab3D (clone C6);
AtT-20 cells expressing Rab
3D N135I (clones A3C1 and
A3C4). The intensity of the
13-kD ACTH band was mea-
sured as described in Materials and Methods. Error bars repre-
sent SEM. The number of experiments is indicated in parenthesis.The Journal of Cell Biology, Volume 140, 1998 312
distribution of tubulin immunoreactivity (data not shown) is
identical in cells expressing endogenous and mutated Rab3D. 
In cells expressing Rab3D N135I, regulated secretion
of ACTH hormone is blocked. However, untransfected
AtT-20 and A3C1 cells expressing mutated Rab3D re-
lease identical levels of hormone precursors. These results
indicate that Rab3D N135I inhibits regulated, but not
constitutive, secretion. AtT-20 and A3C1 cells expressing
Rab3D  N135I process the same fraction of ACTH precur-
sors into mature ACTH hormone. In both cell lines, the
hormone is packaged in organelles with the same density.
We conclude that expression of mutated Rab3D does not
inhibit localization of ACTH to dense core granules. In
A3C1 cells kept in basal conditions, we do not find higher
levels of mature ACTH hormone than in AtT-20 cells.
This result indicates that spontaneous release of processed
ACTH hormone from granules occurs at a similar rate in
unstimulated AtT-20 and A3C1 cells.
In A3C1 cells expressing Rab3D N135I, there are low
levels of Rab3A associated with membranes. We have
shown that the inability of Rab3A to bind to membranes is
not a result of Rab3D overexpression, but a direct conse-
quence of the mutation. Expression of Rab3D N135I does
not impair association of Rab4 with membranes or even
the binding of endogenous, wild-type Rab3D to P2 mem-
branes. We conclude that expression of mutated Rab3D
specifically impairs the ability of Rab3A to associate with
cellular organelles. Rab3A binds to membranes of dense
core granules in adrenal medullary cells and insulin-secret-
ing cells (7, 8, 34). It is reasonable to hypothesize that ex-
pression of mutated Rab3D may impair association of
Rab3A to ACTH-containing granules. This may be at
least one of the defects that make dense core granules of
AtT-20 cells expressing mutated Rab3D unable to exocy-
tose. More work is necessary to understand whether
Rab3A binds to synaptic-like microvesicles and/or to dense
core granules in AtT-20 cells, and how expression of Rab3D
N135I affects Rab3A association with these organelles.
Expression of Rab3D N135I in AtT-20 cells seems to in-
duce the formation of “defective granules” that are sepa-
rated from the Golgi, have normal density and ACTH
content, but are unable to position near the plasma mem-
brane or to exocytose. We speculate that these defective
granules may lack components necessary for efficient vesi-
cle docking and exocytosis. Another possibility is that in
cells expressing mutated Rab3D, granules cannot release
membrane components that function as clamps to prevent
exocytosis.
We thank R. Jahn for the gift of antibodies against VAMP-2 and Rab3A,
P. van der Sluijs for the gift of antibodies against Rab4, T. Swayne, A. Nis-
tri, and L. Khiroug for the images obtained with the confocal microscope,
T.E. McGraw for many helpful dicussions during the peparation of this
work, and Dr. A.-J. Silverman for reading the manuscript.
Figure 9. Equilibrium sucrose density analysis of P2 fractions
from AtT-20 and A3C1 cells. P2 fraction obtained from four 10 cm-
diam plates of AtT-20 or A3C1 cells were resuspended in 0.45 ml
homogenization buffer (see Fig. 11) and loaded onto an 11-ml
continuous 10–60 wt/vol sucrose gradient. After centrifugation
for 17 h in a Beckman SW-41 rotor at 48C fractions (0.8 ml) were
taken from the top. Acetone was added to 0.2-ml aliquots of each
fraction, proteins were precipitated for 16 h at 2208C, resus-
pended in sample buffer, and then loaded into a 15% acrylamide
SDS-PAGE gel. Blots of gels containing AtT-20 and A3C1 sam-
ples were probed with synaptotagmin and ACTH antibodies. The
distribution of 13-kD ACTH hormone (graph, open circles) and
34-kD ACTH precursor (graph, open squares) was determined
by densitometry of the autoradiograms.
Figure 10. Distribution of Rab3A in subcellular fractions from
AtT-20 and A3C1 cells. Homogenates, pellets, and supernatant
fractions of AtT-20 and A3C1 cells were obtained as in Fig. 3.
The lanes of the SDS-PAGE gel (A) were loaded with 40 mg pro-
tein of AtT-20 and A3C1 cell homogenates (H), pellets (P), and
supernatants (S). The blot was probed with the monoclonal anti-
bodies against Rab3A Cl 42.2 (1:1,000 dilution) and rabbit poly-
clonal antibody against Rab4 (1:1,000 dilution). 40 mg of P2 frac-
tions from AtT-20 cells, A3C1 cells expressing Rab3D N135I,
and C6 cells expressing exogenous Rab3D were loaded into SDS-
PAGE gels. Blots were probed with Rab3A, Rab3D, and
VAMP-2 antibodies at 1:1,000 dilution. Bands were visualized by
enhanced chemiluminescence.Baldini et al. Rab3D and ACTH Secretion 313
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